Starling Oncology, Inc. SEC filings STLNW
Starling Oncology, Inc. has 544 filings in SEC EDGAR's recent list, going back to Jan 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 21, 2026 | Aug 20, 2026 |
| 144 | Notice of proposed sale | Aug 21, 2026 | — |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 3, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 22, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jul 16, 2026 | Jul 14, 2026 |
| 144 | Notice of proposed sale | Jul 14, 2026 | — |
| 4 | Insider transaction | Jul 13, 2026 | Jul 10, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 7, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 8, 2026 |
| 144 | Notice of proposed sale | Jun 8, 2026 | — |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 8-K | Current report | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 19, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 17, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 144 | Notice of proposed sale | Apr 14, 2026 | — |
| 4 | Insider transaction | Apr 13, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 20, 2026 |
| 3 | Initial insider ownership | Mar 20, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 13, 2026 |
| 3 | Initial insider ownership | Mar 16, 2026 | Mar 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 16, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2026 | Mar 13, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 23, 2026 | Feb 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 15, 2026 | — |
| 3 | Initial insider ownership | Jan 12, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 7, 2026 | Jan 2, 2026 |
| 4/A | Filing | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 15, 2025 |
| 144 | Notice of proposed sale | Dec 15, 2025 | — |
| 4 | Insider transaction | Dec 1, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 1, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 18, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 18, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 20, 2025 | — |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 18, 2025 | — |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2025 | Nov 3, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 5, 2025 | — |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Aug 21, 2025 | Aug 19, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 424B5 | Prospectus supplement | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 13, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 3 | Initial insider ownership | Jul 22, 2025 | Jul 7, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 24, 2025 | — |
| 4 | Insider transaction | Jun 24, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 17, 2025 |
| EFFECT | Filing | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 16, 2025 | — |
| S-3/A | Form s-3 amendment no. 1 | Jun 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2025 | — |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| S-3 | Shelf registration | Jun 6, 2025 | — |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 144 | Notice of proposed sale | Jun 5, 2025 | — |
| 144 | Notice of proposed sale | Jun 5, 2025 | — |
| 144 | Notice of proposed sale | Jun 3, 2025 | — |
| 144 | Notice of proposed sale | Jun 3, 2025 | — |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 3 | Initial insider ownership | May 23, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2025 | May 19, 2025 |
| EFFECT | Filing | May 16, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| S-3 | Shelf registration | May 8, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change
|
May 7, 2025 | May 2, 2025 |
| 4/A | Filing | Apr 28, 2025 | Mar 26, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 23, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 11, 2025 | Apr 9, 2025 |
| D | Filing | Apr 8, 2025 | — |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 28, 2025 | — |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| DEFA14A | Additional proxy material | Mar 27, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 27, 2025 | Mar 26, 2025 |
| DEF 14A | Proxy statement | Mar 27, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Mar 26, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 25, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 19, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 19, 2025 |
| 4 | Insider transaction | Mar 20, 2025 | Mar 19, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 14, 2025 | May 7, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 26, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 19, 2024 | Dec 19, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 6, 2024 | — |
| 4 | Insider transaction | Dec 5, 2024 | Dec 3, 2024 |
| 4 | Insider transaction | Dec 2, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 20, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 20, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 20, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Nov 18, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2024 | Nov 8, 2024 |
| 3/A | Filing | Oct 8, 2024 | Sep 5, 2023 |
| 3 | Initial insider ownership | Sep 30, 2024 | Sep 20, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 23, 2024 | Sep 19, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 20, 2024 | — |
| 4 | Insider transaction | Aug 20, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cerritos, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1799191
- Former names
- Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.